Literature DB >> 17961182

Involvement of glutathione/glutathione S-transferase antioxidant system in butyrate-inhibited vascular smooth muscle cell proliferation.

Kasturi Ranganna1, Omana P Mathew, Frank M Yatsu, Zivar Yousefipour, Barbara E Hayes, Shirlette G Milton.   

Abstract

Vascular smooth muscle cell (VSMC) proliferation is an important etiological factor in vascular proliferative diseases such as primary atherosclerosis, hypertension, arterial and in-stent restenosis, and transplant vasculopathy. Our studies established that butyrate, a bacterial fermentation product of dietary fiber and a chromatin modulator, is a potent inhibitor of VSMC proliferation. The cardiovascular health benefits of a high-fiber diet, the principle source of butyrate in the body, have been known for a long time, however, very little is known about the antiatherogenic potential of butyrate. Because oxidative stress plays an important role in the pathogenesis of atherosclerosis, we examined involvement of the glutathione/glutathione S-transferase (GST) antioxidant system in butyrate's inhibition of VSMC proliferation. Treatment of proliferating VSMCs with butyrate leads to the induction of several GSTs. Interestingly, our study also demonstrated the nuclear localization of GST-P1 (GST-7-7), which is considered to be a cytosolic protein; this was demonstrated using immunostaining and was corroborated by western blotting. Also, the butyrate-induced antiproliferative action, and the induction of GST-P1 and its nuclear localization are downregulated when butyrate is withdrawn. Furthermore, assessment of intracellular glutathione levels reveals their augmentation by butyrate. Conversely, butyrate treatment reduces the levels of reactive oxygen species in VSMCs. Collectively, the butyrate-treatment-related increase in glutathione content, the reduction in reactive oxygen species, the upregulation of GST and the nuclear localization of GST-P1 in growth-arrested VSMCs imply that butyrate's antiproliferative action involves modulation of the cellular redox state. Thus, induction of the glutathione/GST antioxidant system appears to have other regulatory role(s) besides detoxification and regulation of the cellular redox state, for example, cell-cycle control and cell proliferation, which are both critical to atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17961182     DOI: 10.1111/j.1742-4658.2007.06119.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  14 in total

1.  Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.

Authors:  Omana P Mathew; Kasturi Ranganna; Frank M Yatsu
Journal:  Biomed Pharmacother       Date:  2010-12       Impact factor: 6.529

2.  Reduced Expression of Glutathione S-Transferase α 4 Promotes Vascular Neointimal Hyperplasia in CKD.

Authors:  Jinlong Luo; Guang Chen; Ming Liang; Aini Xie; Qingtian Li; Qunying Guo; Rajendra Sharma; Jizhong Cheng
Journal:  J Am Soc Nephrol       Date:  2017-11-10       Impact factor: 10.121

3.  Glutathione redox dynamics and expression of glutathione-related genes in the developing embryo.

Authors:  Alicia R Timme-Laragy; Jared V Goldstone; Barry R Imhoff; John J Stegeman; Mark E Hahn; Jason M Hansen
Journal:  Free Radic Biol Med       Date:  2013-06-13       Impact factor: 7.376

4.  The common variant in the GSTM1 and GSTT1 genes is related to markers of oxidative stress and inflammation in patients with coronary artery disease: a case-only study.

Authors:  Jian-Jin Tang; Ming-Wei Wang; En-zhi Jia; Jian-Jun Yan; Qi-Ming Wang; Jun Zhu; Zhi-Jian Yang; Xiang Lu; Lian-sheng Wang
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

5.  The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats.

Authors:  Xiaoxi B Lin; Arazm Farhangfar; Rosica Valcheva; Michael B Sawyer; Levinus Dieleman; Andreas Schieber; Michael G Gänzle; Vickie Baracos
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240

6.  Involvement of the Antioxidant Effect and Anti-inflammatory Response in Butyrate-Inhibited Vascular Smooth Muscle Cell Proliferation.

Authors:  Omana P Mathew; Kasturi Ranganna; Shirlette G Milton
Journal:  Pharmaceuticals (Basel)       Date:  2014-11-10

7.  Histone deacetylase inhibitors promote eNOS expression in vascular smooth muscle cells and suppress hypoxia-induced cell growth.

Authors:  Xiaoling Tan; Lan Feng; Xiaoyong Huang; Yidong Yang; Chengzhong Yang; Yuqi Gao
Journal:  J Cell Mol Med       Date:  2017-03-07       Impact factor: 5.310

Review 8.  The Role of Gut Dysbiosis in the Bone-Vascular Axis in Chronic Kidney Disease.

Authors:  Pieter Evenepoel; Sander Dejongh; Kristin Verbeke; Bjorn Meijers
Journal:  Toxins (Basel)       Date:  2020-04-29       Impact factor: 4.546

9.  High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE-/- mice.

Authors:  Yee Kwan Chan; Manreetpal Singh Brar; Pirkka V Kirjavainen; Yan Chen; Jiao Peng; Daxu Li; Frederick Chi-Ching Leung; Hani El-Nezami
Journal:  BMC Microbiol       Date:  2016-11-08       Impact factor: 3.605

10.  iTRAQ-Based Quantitative Proteomics Analysis of the Protective Effect of Yinchenwuling Powder on Hyperlipidemic Rats.

Authors:  Zheyu Zhang; Wenbo Wang; Ling Jin; Xin Cao; Gonghui Jian; Ning Wu; Xia Xu; Ye Yao; Dongsheng Wang
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-14       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.